Inhibition of Mycobacterial Growth In Vitro following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG

Despite the widespread use of the Mycobacterium bovis BCG vaccine, there are more than 9 million new cases of tuberculosis (TB) every year, and there is an urgent need for better TB vaccines. TB vaccine candidates are selected for evaluation based in part on the detection of an antigen-specific gamm...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fletcher, Helen A., Tanner, Rachel, Wallis, Robert S., Meyer, Joel, Manjaly, Zita-Rose, Harris, Stephanie, Satti, Iman, Silver, Richard F., Hoft, Dan, Kampmann, Beate, Walker, K. Barry, Dockrell, Hazel M., Fruth, Uli, Barker, Lew, Brennan, Michael J., McShane, Helen
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837779/
https://ncbi.nlm.nih.gov/pubmed/23986316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00427-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars